Literature DB >> 28378198

Sharkquinone, a new ana-quinonoid tetracene derivative from marine-derived Streptomyces sp. EGY1 with TRAIL resistance-overcoming activity.

Mohamed S Abdelfattah1,2, Mohammed I Y Elmallah3,4, Adal A Mohamed4, Masami Ishibashi5.   

Abstract

A new ana-quinonoid tetracene metabolite, named sharkquinone (1), and the known SS-228R (2) have been isolated from the ethyl acetate extract of the culture of marine Streptomyces sp. EGY1. The strain was isolated from sediment sample collected from the Red Sea coast of Egypt. The structure of sharkquinone (1) was elucidated using detailed spectral (HRESI-MS, 1D and 2D NMR) analyses and quantum chemical calculations. This is the first report of the isolation of ana-quinonoid tetracene derivative from a natural source. Compound 1 showed the ability to overcome tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) resistance at a concentration of 10 μM in human gastric adenocarcinoma (AGS) cells.

Entities:  

Keywords:  Actinomycetes; Spectroscopy; TRAIL; ana-Quinonoid

Mesh:

Substances:

Year:  2017        PMID: 28378198     DOI: 10.1007/s11418-017-1086-5

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  26 in total

1.  Biogeography of the marine actinomycete Salinispora.

Authors:  Paul R Jensen; Chrisy Mafnas
Journal:  Environ Microbiol       Date:  2006-11       Impact factor: 5.491

Review 2.  TRAIL/Apo-2L: mechanisms and clinical applications in cancer.

Authors:  R K Srivastava
Journal:  Neoplasia       Date:  2001 Nov-Dec       Impact factor: 5.715

3.  Yoropyrazone, a new naphthopyridazone alkaloid isolated from Streptomyces sp. IFM 11307 and evaluation of its TRAIL resistance-overcoming activity.

Authors:  Mohamed S Abdelfattah; Kazufumi Toume; Masami Ishibashi
Journal:  J Antibiot (Tokyo)       Date:  2012-02-22       Impact factor: 2.649

4.  Nitrosporeusines A and B, unprecedented thioester-bearing alkaloids from the Arctic Streptomyces nitrosporeus.

Authors:  Aigang Yang; Longlong Si; Zhenping Shi; Li Tian; Dong Liu; Demin Zhou; Peter Proksch; Wenhan Lin
Journal:  Org Lett       Date:  2013-10-03       Impact factor: 6.005

5.  Novel bioactive metabolites from a marine derived bacterium Nocardia sp. ALAA 2000.

Authors:  Mervat M A El-Gendy; Usama W Hawas; Marcel Jaspars
Journal:  J Antibiot (Tokyo)       Date:  2008-06       Impact factor: 2.649

Review 6.  TRAIL and apoptosis induction by TNF-family death receptors.

Authors:  Shulin Wang; Wafik S El-Deiry
Journal:  Oncogene       Date:  2003-11-24       Impact factor: 9.867

Review 7.  Bioactive Secondary Metabolites with Unique Aromatic and Heterocyclic Structures Obtained from Terrestrial Actinomycetes Species.

Authors:  Mohamed S Abdelfattah; Midori A Arai; Masami Ishibashi
Journal:  Chem Pharm Bull (Tokyo)       Date:  2016-03-02       Impact factor: 1.645

8.  The fluorometric microculture cytotoxicity assay.

Authors:  Elin Lindhagen; Peter Nygren; Rolf Larsson
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

9.  Egypt's Red Sea coast: phylogenetic analysis of cultured microbial consortia in industrialized sites.

Authors:  Ghada A Mustafa; Amr Abd-Elgawad; Alyaa M Abdel-Haleem; Rania Siam
Journal:  Front Microbiol       Date:  2014-08-11       Impact factor: 5.640

Review 10.  Trailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cells.

Authors:  Rachana Trivedi; Durga Prasad Mishra
Journal:  Front Oncol       Date:  2015-04-02       Impact factor: 6.244

View more
  2 in total

Review 1.  Screening study of cancer-related cellular signals from microbial natural products.

Authors:  Masami Ishibashi
Journal:  J Antibiot (Tokyo)       Date:  2021-06-30       Impact factor: 2.649

2.  Marine Actinomycetes-Derived Secondary Metabolites Overcome TRAIL-Resistance via the Intrinsic Pathway through Downregulation of Survivin and XIAP.

Authors:  Mohammed I Y Elmallah; Sheron Cogo; Andrei A Constantinescu; Selene Elifio-Esposito; Mohammed S Abdelfattah; Olivier Micheau
Journal:  Cells       Date:  2020-07-22       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.